Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,123
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
for
Bronchiectasis
Location: New Hyde Park NY, Williamsburg VA, Rockville MD,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07201051
Phase 2, Recruiting
Boosting Olfactory and Sensory Training Study (BOOST)
for
HIV (Human Immunodeficiency Virus)
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 40+
Code: NCT07221123
Phase 2, Recruiting
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
for
Irritable Bowel Syndrome
Location: Boston MA, North Massapequa NY, Richmond Hill NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07519395
Phase 2, Recruiting
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
for
Meibomian Gland Dysfunction (MGD)
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT07224529
Recruiting
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
for
Carcinoma, Non-Small-Cell Lung, Lung Cancer (NSCLC),
Location: Athens GA, Knoxville TN, Huntsville AL, Hinsdale IL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07489066
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease